Literature DB >> 20307983

A 3 months mild functional test regime does not affect disease parameters in young mdx mice.

Maaike van Putten1, Christa de Winter, Willeke van Roon-Mom, Gert-Jan van Ommen, Peter A C 't Hoen, Annemieke Aartsma-Rus.   

Abstract

To assess the effect of potential therapeutic agents in dystrophic mice it is useful to have a functional test regime that does not affect the natural disease progression of mdx mice with dystrophinopathy. We determined the effect of a 12 week test regime consisting of fore limb grip strength, rotarod analysis and two and four limb hanging wire tests on the disease progression of 4-week-old mdx mice. Mice performed the different functional tests on consecutive days on a weekly basis. No difference was found in serum creatine kinase levels between functionally active and sedentary mice. The percentage of fibrotic/necrotic areas assessed in a semi-automated way with colour deconvolution of skeletal muscles, heart and diaphragm did not vary within muscles or between groups, nor did the gene expression levels of disease-related genes. We conclude that this test regime may be suitable for short-term functional evaluation of therapeutic approaches in the mdx mouse. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20307983     DOI: 10.1016/j.nmd.2010.02.004

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  21 in total

1.  Age-related T2 changes in hindlimb muscles of mdx mice.

Authors:  Ravneet S Vohra; Sunita Mathur; Nathan D Bryant; Sean C Forbes; Krista Vandenborne; Glenn A Walter
Journal:  Muscle Nerve       Date:  2015-07-14       Impact factor: 3.217

2.  Longitudinal metabolomic analysis of plasma enables modeling disease progression in Duchenne muscular dystrophy mouse models.

Authors:  Roula Tsonaka; Mirko Signorelli; Ekrem Sabir; Alexandre Seyer; Kristina Hettne; Annemieke Aartsma-Rus; Pietro Spitali
Journal:  Hum Mol Genet       Date:  2020-03-27       Impact factor: 6.150

3.  Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates.

Authors:  Kenji Rowel Q Lim; Yusuke Echigoya; Tetsuya Nagata; Mutsuki Kuraoka; Masanori Kobayashi; Yoshitsugu Aoki; Terence Partridge; Rika Maruyama; Shin'ichi Takeda; Toshifumi Yokota
Journal:  Mol Ther       Date:  2018-10-19       Impact factor: 11.454

4.  Rutin and orlistat produce antitumor effects via antioxidant and apoptotic actions.

Authors:  Amira Saleh; Hassan M ElFayoumi; Mahmoud Youns; Waleed Barakat
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-11-21       Impact factor: 3.000

5.  BMP antagonists enhance myogenic differentiation and ameliorate the dystrophic phenotype in a DMD mouse model.

Authors:  SongTing Shi; Willem M H Hoogaars; David J J de Gorter; Sandra H van Heiningen; Herbert Y Lin; Charles C Hong; Dwi U Kemaladewi; Annemieke Aartsma-Rus; Peter ten Dijke; Peter A C 't Hoen
Journal:  Neurobiol Dis       Date:  2010-10-16       Impact factor: 5.996

6.  Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy.

Authors:  Refik Kayali; Jin-Mo Ku; Gregory Khitrov; Michael E Jung; Olga Prikhodko; Carmen Bertoni
Journal:  Hum Mol Genet       Date:  2012-06-12       Impact factor: 6.150

7.  Decreased sensory responses in osteocalcin null mutant mice imply neuropeptide function.

Authors:  Patricia Patterson-Buckendahl; Agnieszka Sowinska; Stephanie Yee; Dhara Patel; Stephen Pagkalinawan; Muhammad Shahid; Ankit Shah; Christopher Franz; Daniel E Benjamin; Larissa A Pohorecky
Journal:  Cell Mol Neurobiol       Date:  2012-02-17       Impact factor: 5.046

8.  Functional muscle recovery with nanoparticle-directed M2 macrophage polarization in mice.

Authors:  Theresa M Raimondo; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

9.  Assessing functional performance in the mdx mouse model.

Authors:  Annemieke Aartsma-Rus; Maaike van Putten
Journal:  J Vis Exp       Date:  2014-03-27       Impact factor: 1.355

10.  Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice.

Authors:  Maaike van Putten; Margriet Hulsker; Courtney Young; Vishna D Nadarajah; Hans Heemskerk; Louise van der Weerd; Peter A C 't Hoen; Gert-Jan B van Ommen; Annemieke M Aartsma-Rus
Journal:  FASEB J       Date:  2013-03-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.